If none of your atopic dermatitis treatments have worked, you may be experiencing burnout (or treatment fatigue). Here's what ...

ZORYVE cream 0.05% was safe and well-tolerated, with efficacy that was maintained and improved over time up to 56 weeks of treatmentChildren ages ...

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of ...

Aclaris Therapeutics (NASDAQ:ACRS) outlined multiple clinical and near-term development milestones across its large-molecule and small-molecule pipeline during a presentation at the Leerink Partners ...

Abrocitinib shows sustained improvement in atopic dermatitis symptoms over two years with an acceptable safety profile.

At the Winter Clinical Dermatology Meeting, April W. Armstrong, MD, MPH, professor and chief of dermatology at the UCLA ...

Among patients with AD, receipt of JAK inhibitors was associated with an increased risk for acne compared with Th2 cytokine inhibitors.

Minimal disease activity in atopic dermatitis is sustainable at one year in early responders. Discover predictors and ...

Atopic dermatitis flares can cause skin cracks and bleeding. Learn how to care for the wounds and spot signs of infection.

A study published in JAAD has found that high-dose Vitamin D during pregnancy may help prevent atopic dermatitis in children of mothers exposed to tobacco smoke. In a post-hoc analysis of ...

Galderma has significantly raised its peak annual sales estimate for Nemluvio (nemolizumab) to more than $4 billion | Galderma has doubled its peak annual sales estimate for Nemluvio (nemolizumab) to ...